Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2011 Issue 13
Utilization of narcotic analgesics in 5 hospitals in Xinjiang area during 2006-2009
LIANG Yong-hong1;XU Qiang2;HUANG Li3;WANG Wei4
..............page:1251-1254
Preparation of ibuprofen arginine injection and its stability
HAN Jing;WANG Zhen-long;WANG Xiao-lin;WANG Guo-cai;LIU Hui-chen
..............page:1247-1250
Problems in essential medicine sales of retail pharmacies in China and the countermeasures
CUI Xia-zi;CHEN Li;ZHANG Hong;SUN Li-hua
..............page:1155-1157,1169
Gene expression profiles of rifampicin-injured rat liver using cDNA micoarray
LIAO Yan2;PENG Shuang-qing1;ZHANG Li-shi3
..............page:1212-1216
Clinical diagnosis and treatment guided by proteomics
LI Yi-shi
..............page:1179-1182,1187
Progress in the pharmacogenomics of infectious diseases
CAO Shan;WU Hui-zi;ZHOU Gan;ZHANG Wei;ZHOU Hong-hao
..............page:1198-1202,1221
Efficacy and safety of Tongqiao Biyan capsule in the treatment of allergic rhinitis
XU Shui-lian1;QIAO Feng-ying2;WANG De-hong1
..............page:1233-1235,1246
Effect of UGT genetic polymorphisms on individual difference of mitiglinide pharmacokinetics in Chinese
XU Jing-feng;YAN Chen-xia;YANG Yong-ge;XU Qian;XU Lin;ZHAO Gang-tao;YANG Fan
..............page:1222-1228
Bibliometric analysis of pharmacogenomic literature based on Web of Science
ZHAO Nan1;2;ZHANG Ya-tong2;CHENG Gang1;HU Xin2
..............page:1194-1197,1211
Reformation of intermediate sector of drug circulation by analyzing the characteristics of drug circulation
LI Hao-na1;2;ZHAO Wen-jiao1;JIA Hui2;MA Cheng-yan1
..............page:1158-1160,1178
The discussion on several key questions in human bioequivalence study of oral preparation of terazosin hydrochloride
QIANG Gui-fen;YANG Man;ZHANG Ya-nan;LIU Man;ZHANG Dan;LIU Hui-chen
..............page:1229-1232
WINDOW OF NEW DRUGS
..............page:1149-1150
Preparation and evaluation of propofol injectable microemulsion
CAI Wei-hui1;CHEN Xiao-ping2;JIN Fang1
..............page:1170-1173
Progress in the pharmacogenomics of rheumatic diseases
CHEN Yao;ZHANG Wei;ZHOU Hong-hao
..............page:1203-1206,1232
Research advances in pharmacogenetics and adverse drug reactions
CHEN Wang-qing;ZHANG Wei
..............page:1207-1211
Pharmacokinetic study of PUM100 after a single intravenous administration to cynomolgus monkey
LI Zuo-gang1;GAI Wen-lin2;WEN Nie1;TANG Yao1;SUN Xu1;YU Min1; WANG Xiu-wen1;WANG Jun-zhi1;LI Bo1
..............page:1165-1169
Preparation of glaucocalyxin A-hydroxypropy-β-cyclodextrin inclusion complex
SHANG Xiao-jun1;MA Su-ying1;WU Jing2;BAI Su-ping1
..............page:1243-1246
Efficacy of Fufang Kushen injection combined with chemotherapy on advanced non-small cell lung cancer
FENG Li-hua;CHEN Yi-de;LI Xiao-mei;GAO Ying-qin
..............page:1236-1238
Study on quality standard of Guchong Zhixue granule
ZHANG Xue-lan1;TANG Yu-qiu2;LI Hui-fen1;TANG Chao1
..............page:1174-1178
Progress in the pharmacogenomics of UDP-glucuronosyltransferase
GUO Dong;PANG Liang-fang;ZHOU Hong-hao
..............page:1188-1193
Effects of CYP2C19 and CYP2C9 polymorphisms on the pharmacodynamics of clopidogrel in healthy Chinese
JIANG Juan-juan;TIAN Lei;HAN Lu-lu;YAN Yan;HUANG Yi-ling;LIU Hong;XIE Shuang;LI Yi-shi
..............page:1217-1221
yao qing han
song rui lin
..............page:1142
Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by LC-MS/MS
MENG Fan-hua1;GUO Ji-fen1;LI Li1;2;LIU Hai-pei1;3;ZHAO Yi-min1
..............page:1239-1242,1254
Validation of sterilizing grade filters(Ⅱ):sterilization efficiency
XIE Ting1;TANG Yan1;DONG Wei1;HONG Hai-yan1;CAI Qing-bo1;HUANG Xiao-long2
..............page:1161-1164